Athersys Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (50)

Latest Posts

About This Stock More About This Stock
E Market Briefing For Tuesday, Dec. 22
Article By: Gene Inger
Tuesday, December 22, 2020 3:59 AM EST
Big-caps remain extended, as bears continue 'fighting the Fed', even as for sure, a post-Expiration pause would be normal, but Tesla might mix that up.
In this article: ATHX Also: LLY, SRNE, REGN, TSLA, SPX
Read
E Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
Article By: James Gornick
Wednesday, July 22, 2020 5:50 AM EST
In recent months, there has been a flurry of activity within the clinical trial sector. When all trial types are considered, there are over 400 studies exploring approaches to diagnosing, treating, or preventing COVID-19.
In this article: CAPR, ATHX Also: BMRN, AZN, PFE, INO, NVAX, REGN, XLY, MRNA, BNTX, SRNE
Read
E Athersys Inc. Announces Positive Phase 2 Stroke Results
Article By: Terry Chrisomalis
Thursday, February 18, 2016 12:50 AM EST
Athersys up 21% in after-hours trade after announcing positive phase 2 stroke trial results.
In this article: ATHX
Read
E Athersys Fails Stroke Trial In Mid-Stage Study
Article By: Terry Chrisomalis
Friday, April 17, 2015 12:02 PM EST
Shares of Athersys are down almost 50% on the news of failing a phase 2 trial for stroke with the company using its multistem cell therapy
In this article: ATHX, PFE
Read
EC Convert Catalysts Into Profits: Sagient Research's Edward Stopke
Article By: The Life Sciences Report
Friday, January 23, 2015 5:48 PM EST
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. Edward Stopke of Sagient Research unveils his list of companies with catalytic moments in the making.
In this article: PSTV, VCEL, ATHX, BLUE, CUR, KITE, NVS, AMGN, JUNO, RNN, MRK, ESALF, RPTP, CLDX, SRPT, PTCT, GILD, RMTI
Read

Latest Tweets for $ATHX

No tweets yet!